During the bead preparation process, the aqueous phase was collected, and the drug content in the aqueous phase was determined. For FITC-dextran by fluorescence measurements (Fluorescence Spectrophotometer, model F-4000, HITACHI), and for BB by UV-visible spectrophotometric measurements at 590 nm (Murata et al., 1993).
Full-size image (